Cargando…

Correction: Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus

Detalles Bibliográficos
Autores principales:	Zhao, Xing, Ouyang, Weiwei, Chester, Cariad, Long, Shiqi, Wang, Nianxue, He, Zhixu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785024/ https://www.ncbi.nlm.nih.gov/pubmed/29370283 http://dx.doi.org/10.1371/journal.pone.0192090

Ejemplares similares

Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus
por: Zhao, Xing, et al.
Publicado: (2017)

Reovirus enhances cytotoxicity of natural killer cells against colorectal cancer via TLR3 pathway
por: Long, Shiqi, et al.
Publicado: (2021)

Past, Present and Future of Oncolytic Reovirus
por: Müller, Louise, et al.
Publicado: (2020)

Reovirus activated NK cells show enhanced cetuximab mediated antibody-dependent cellular cytotoxicity against colorectal cancer cells
por: Zhao, Xing, et al.
Publicado: (2015)

Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics
por: Harrington, K.J., et al.
Publicado: (2010)

Oncolytic Reovirus in Canine Mast Cell Tumor
por: Hwang, Chung Chew, et al.
Publicado: (2013)

Oncolytic Reovirus Infection Is Facilitated by the Autophagic Machinery
por: Kemp, Vera, et al.
Publicado: (2017)

Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells
por: Sei, Shizuko, et al.
Publicado: (2009)

Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites
por: Jennings, VA, et al.
Publicado: (2014)

The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro
por: Alain, T, et al.
Publicado: (2006)

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
por: Heinemann, Lucy, et al.
Publicado: (2011)

The oncolytic effects of reovirus in canine solid tumor cell lines
por: IGASE, Masaya, et al.
Publicado: (2015)

Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus
por: Kemp, Vera, et al.
Publicado: (2015)

Role of Myeloid Cells in Oncolytic Reovirus-Based Cancer Therapy
por: Kumar, Vishnupriyan, et al.
Publicado: (2021)

Combined Therapy with Cytokine-Induced Killer Cells and Oncolytic Adenovirus Expressing IL-12 Induce Enhanced Antitumor Activity in Liver Tumor Model
por: Yang, Zhi, et al.
Publicado: (2012)

Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy
por: Chester, Cariad, et al.
Publicado: (2015)

Correction: A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery
Publicado: (2020)

Correction: Two roads for oncolytic immunotherapy development
Publicado: (2021)

Cytokine-induced killer cells promote antitumor immunity
por: Jiang, Jingting, et al.
Publicado: (2013)

Anti-tumor efficacy of oncolytic reovirus against gastrointestinal stromal tumor cells
por: Inagaki, Yusuke, et al.
Publicado: (2017)

Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
por: Berry, Jameson T.L., et al.
Publicado: (2020)

Updates to the antitumor mechanism of oncolytic virus
por: Bai, Yang, et al.
Publicado: (2019)

Mesenchymal stem cell carriers enhance anti-tumor efficacy of oncolytic virotherapy
por: Wang, Xianyao, et al.
Publicado: (2021)

Correction to: Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
por: Draganov, Dobrin D., et al.
Publicado: (2021)

Author Correction: Reovirus directly engages integrin to recruit clathrin for entry into host cells
por: Koehler, Melanie, et al.
Publicado: (2021)

Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis
por: Gebremeskel, Simon, et al.
Publicado: (2021)

Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia
por: Parrish, C, et al.
Publicado: (2015)

Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models
por: Le Boeuf, Fabrice, et al.
Publicado: (2017)

Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma
por: Cooper, Timothy, et al.
Publicado: (2015)

Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer
por: Samson, Adel, et al.
Publicado: (2018)

Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy
por: Kelly, Kevin R., et al.
Publicado: (2017)

Oncolytic Reovirus and Immune Checkpoint Inhibition as a Novel Immunotherapeutic Strategy for Breast Cancer
por: Mostafa, Ahmed A., et al.
Publicado: (2018)

Kinetics of Oncolytic Reovirus T3D Replication and Growth Pattern in Mesenchymal Stem Cells
por: Banijamali, Razieh Sadat, et al.
Publicado: (2020)

Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
por: Vera, Beatriz, et al.
Publicado: (2016)

Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy
por: Dymova, Maya A., et al.
Publicado: (2022)

Correction: Piscine Reovirus: Genomic and Molecular Phylogenetic Analysis from Farmed and Wild Salmonids Collected on the Canada/US Pacific Coast
por: Siah, Ahmed, et al.
Publicado: (2016)

Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment
por: Cristi, Francisca, et al.
Publicado: (2023)

Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecan
por: Maitra, Radhashree, et al.
Publicado: (2014)

Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus
por: Kelly, Kevin R., et al.
Publicado: (2015)

Altered Glycan Expression on Breast Cancer Cells Facilitates Infection by T3 Seroptype Oncolytic Reovirus
por: Mohammed, Danahe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8o30h8p7l1v1ejq7n8rvhcp1or